These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25548141)

  • 1. Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study.
    Shimizu M; Hoshide S; Ishikawa J; Yano Y; Eguchi K; Kario K
    Am J Hypertens; 2015 Aug; 28(8):980-6. PubMed ID: 25548141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
    Shimizu M; Ishikawa J; Yano Y; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K
    J Hypertens; 2012 May; 30(5):1015-21. PubMed ID: 22406464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nighttime home blood pressure and the risk of hypertensive target organ damage.
    Ishikawa J; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K;
    Hypertension; 2012 Oct; 60(4):921-8. PubMed ID: 22892810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is home blood pressure variability itself an interventional target beyond lowering mean home blood pressure during anti-hypertensive treatment?
    Hoshide S; Yano Y; Shimizu M; Eguchi K; Ishikawa J; Kario K
    Hypertens Res; 2012 Aug; 35(8):862-6. PubMed ID: 22476230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between home arterial stiffness index and target organ damage in hypertension: comparison with pulse wave velocity and augmentation index.
    Matsui Y; Ishikawa J; Shibasaki S; Shimada K; Kario K
    Atherosclerosis; 2011 Dec; 219(2):637-42. PubMed ID: 21978919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study.
    Hoshide S; Kario K; Yano Y; Haimoto H; Yamagiwa K; Uchiba K; Nagasaka S; Matsui Y; Nakamura A; Fukutomi M; Eguchi K; Ishikawa J;
    Am J Hypertens; 2014 Jul; 27(7):939-47. PubMed ID: 24473255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Change in Central Nocturnal Blood Pressure and Urine Albumin-Creatinine Ratio by a Valsartan/Amlodipine Combination: A CPET Study.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Hashimoto J; Kario K
    Am J Hypertens; 2018 Aug; 31(9):995-1001. PubMed ID: 29850782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
    Kario K; Hoshide S; Shimizu M; Yano Y; Eguchi K; Ishikawa J; Ishikawa S; Shimada K
    J Hypertens; 2010 Jul; 28(7):1574-83. PubMed ID: 20404743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension.
    Matsui Y; Ishikawa J; Eguchi K; Shibasaki S; Shimada K; Kario K
    Hypertension; 2011 Jun; 57(6):1087-93. PubMed ID: 21536993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A blood pressure independent association between glomerular albumin leakage and electrocardiographic left ventricular hypertrophy. The LIFE Study. Losartan Intervention For Endpoint reduction.
    Olsen MH; Wachtell K; Borch-Johnsen K; Okin PM; Kjeldsen SE; Dahlöf B; Devereux RB; Ibsen H
    J Hum Hypertens; 2002 Aug; 16(8):591-5. PubMed ID: 12149666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of antihypertensive therapy for reduction in left ventricular mass.
    Hashimoto J; Imai Y; O'Rourke MF
    Am J Hypertens; 2007 Nov; 20(11):1229-33. PubMed ID: 17954372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study.
    Eguchi K; Hoshide S; Komori T; Nagasaka S; Kario K
    Am J Hypertens; 2015 Aug; 28(8):971-9. PubMed ID: 25528450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
    Mori H; Yamamoto H; Ukai H; Yuasa S; Nakajima K; Mikawa T; Niizuma M; Hirao K; Umemura S;
    Hypertens Res; 2013 Mar; 36(3):202-7. PubMed ID: 23013888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of arterial stiffness reduction on urinary albumin excretion during antihypertensive treatment: the Japan morning Surge-1 study.
    Matsui Y; Eguchi K; Shibasaki S; Ishikawa J; Hoshide S; Shimada K; Kario K;
    J Hypertens; 2010 Aug; 28(8):1752-60. PubMed ID: 20485195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects.
    Spratt JC; Webb DJ; Shiels A; Williams B
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):227-32. PubMed ID: 11881128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
    Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
    J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning rise of blood pressure assessed by home blood pressure monitoring is associated with left ventricular hypertrophy in hypertensive patients receiving long-term antihypertensive medication.
    Shibuya Y; Ikeda T; Gomi T
    Hypertens Res; 2007 Oct; 30(10):903-11. PubMed ID: 18049021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amlodipine, efonidipine, and trichlormethiazide on home blood pressure and upper-normal microalbuminuria assessed by casual spot urine test in essential hypertensive patients.
    Hosaka M; Inoue R; Satoh M; Watabe D; Hanazawa T; Ohkubo T; Asayama K; Obara T; Imai Y;
    Clin Exp Hypertens; 2018; 40(5):468-475. PubMed ID: 29172732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.